Nature's Sunshine Products, Inc. (NATR) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time NATR price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 22.8 Oversold
Market Cap $272.7M
Volume 234.4K
Fundamentals — 10-Q Q2 2026
Revenue $239.9M
Net Income $8.7M
EPS $0.48
Gross Margin 73.4%
Operating Margin 6.3%
Net Margin 3.6%
P/E Ratio 32.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Prescott Group Capital Management, L.l.c. | 10% Owner | Buy | 141,389 | $16.40 | $2.3M | 2026 Aug 10 |
| Herbert Kevin R. | EVP & President, North America | Sell | 2,000 | $20.68 | $41,364 | 2026 Jun 12 |
| Yates Bryant J | EVP & President, Europe | Sell | 11,968 | $19.90 | $238,163 | 2026 Jun 5 |
| Norman Daniel C | EVP & President, Asia | Sell | 9,713 | $20.64 | $200,476 | 2026 Jun 1 |
| Brower Nathan G | EVP, General Counsel | Sell | 12,015 | $21.84 | $262,408 | 2026 May 21 |
| Yates Bryant J | EVP & President, Europe | Sell | 19,516 | $24.35 | $475,215 | 2026 Mar 13 |
| Norman Daniel C | EVP & President, Asia | Sell | 15,383 | $24.52 | $377,191 | 2026 Mar 13 |
| Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 4,000 | $24.70 | $98,800 | 2026 Mar 13 |
| Yates Bryant J | EVP & President, Europe | Sell | 1,700 | $22.29 | $37,893 | 2025 Dec 12 |
| Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 5,000 | $20.45 | $102,250 | 2025 Nov 18 |
| Brower Nathan G | EVP, General Counsel | Sell | 3,800 | $20.81 | $79,078 | 2025 Nov 14 |
| Norman Daniel C | EVP & President, Asia | Sell | 8,884 | $20.46 | $181,767 | 2025 Nov 12 |
| Yates Bryant J | EVP & President, Europe | Sell | 9,672 | $16.74 | $161,919 | 2025 Aug 29 |
| Lanoy Jonathan David | SVP, Chief Accounting Officer | Sell | 5,000 | $16.51 | $82,550 | 2025 Aug 13 |
| Brower Nathan G | EVP, General Counsel | Sell | 9,996 | $16.54 | $165,334 | 2025 Aug 13 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Sell | 2,854,607 | $11.46 | $32.7M | 2025 Jun 27 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Sell | 2,300 | $13.02 | $29,946 | 2024 Oct 15 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Sell | 10,895 | $13.33 | $145,189 | 2024 Oct 14 |
| Yates Bryant J | EVP & President, Europe | Sell | 3,068 | $15.30 | $46,940 | 2024 Jun 6 |
| Norman Daniel C | EVP & President, Asia | Sell | 15,000 | $17.13 | $256,960 | 2023 Nov 30 |
Take NATR further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NATR in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Nature's Sunshine Products, Inc. next reports.
Set alerts on NATR
Get notified when Nature's Sunshine Products, Inc. hits your price targets or technical conditions are met.
Get Started Free